NIH-funded study finds many patients with retinal vein occlusion have vision benefits, but require long-term monitoring and treatment.
NIH-funded study finds many patients with retinal vein occlusion have vision benefits, but require long-term monitoring and treatment.
ORNL neural network study harnesses made-to-order design to pair properties to materials
A study led by researchers at ORNL could help make materials design as customizable as point-and-click.
The study enrolled approximately 5,000 mothers and 6,000 children born between 2008 and 2010.
In her 2022 State of the University address, President Kristina M. Johnson emphasized The Ohio State University’s role in attracting Intel’s new semiconductor campus to Ohio and implementing the Scarlet and Gray Advantage program to give undergraduate students the opportunity for a debt-free education, and announced a record $1.24 billion in research and development.
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as scientists, and their collaborations at the Wyss Institute and beyond. Early in his professional life, Vaskar Gnyawali realized he wasn’t content sitting in front of a computer screen all day, so he shifted from software…
With an upcoming U.S. Supreme Court decision that is likely to further restrict abortion access, two new studies from The Ohio State University provide insights into what additional limits on abortion care could mean, particularly for those who will have to travel across state lines.
Wullschleger receives Commitment to Human Diversity in Ecology Award
Stan Wullschleger, associate laboratory director for biological and environmental systems science at ORNL, is the recipient of the 2022 Commitment to Human Diversity in Ecology Award from the Ecological Society of America, or ESA.
Radu Custelcean: Removing carbon dioxide from the atmosphere
Radu Custelcean, an organic chemist at the Department of Energy’s Oak Ridge National Laboratory, is working with colleagues to develop an energy-efficient and sustainable
Tissue chip platform shows potential uses for developing treatments for rare diseases.
A first-of-its-kind national study has found that a special program adopted in many states to help some families at risk of child maltreatment has been surprisingly successful.